Nonergot Dopamine Agonist [EPC]

Nonergot Dopamine Agonist [EPC] was reported 15621 times

Drugs of the Nonergot Dopamine Agonist [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 RESTLESS LEG AUGMENTATION SYNDROME 51 0.3290
1 PARKINSONIAN CRISIS 22 0.2136
2 DOPAMINE DYSREGULATION SYNDROME 93 0.2085
3 PARKINSONISM HYPERPYREXIA SYNDROME 31 0.1732
4 STOMA SITE INDURATION 18 0.1513
5 NEUROPROSTHESIS IMPLANTATION 21 0.1511
6 STOMA SITE ODOUR 28 0.1250
7 ON AND OFF PHENOMENON 665 0.1197
8 STOMA SITE REACTION 81 0.1182
9 STOMA SITE ERYTHEMA 206 0.1102
10 STOMA SITE EXTRAVASATION 42 0.1088
11 JEALOUS DELUSION 30 0.1060
12 FREEZING PHENOMENON 381 0.1028
13 DROPPED HEAD SYNDROME 40 0.1013
14 STOMA SITE DISCHARGE 273 0.0996
15 STOMA SITE HYPERGRANULATION 62 0.0983
16 STOMA SITE PAIN 140 0.0952
17 DEEP BRAIN STIMULATION 57 0.0944
18 REDUCED FACIAL EXPRESSION 94 0.0926
19 STOMA SITE INFLAMMATION 68 0.0910
20 SLEEP ATTACKS 42 0.0882
21 STOMA SITE IRRITATION 42 0.0772
22 HYPERKINESIA 158 0.0745
23 IMPULSE-CONTROL DISORDER 153 0.0743
24 PARKINSONIAN GAIT 45 0.0721
25 HYPERSEXUALITY 129 0.0705
26 STOMA SITE INFECTION 85 0.0653
27 RAPID EYE MOVEMENT SLEEP BEHAVIOUR DISORDER 26 0.0647
28 COMPULSIONS 43 0.0646
29 FIBROMA 59 0.0642
30 PRODUCT ADHESION ISSUE 1985 0.0555
31 COMPULSIVE SHOPPING 107 0.0520
32 SEXUALLY INAPPROPRIATE BEHAVIOUR 24 0.0515
33 BRADYKINESIA 294 0.0498
34 CATHETER SITE BRUISE 16 0.0483
35 GAMBLING 56 0.0480
36 STEREOTYPY 43 0.0456
37 STOMA SITE HAEMORRHAGE 68 0.0441
38 AKINESIA 88 0.0425
39 SUDDEN ONSET OF SLEEP 56 0.0403
40 INFUSION SITE INDURATION 58 0.0391
41 DEVICE LOOSENING 33 0.0382
42 MUSCLE RIGIDITY 450 0.0376
43 RESTLESS LEGS SYNDROME 677 0.0372
44 ORTHOSTATIC INTOLERANCE 26 0.0362
45 PARKINSON'S DISEASE 90 0.0354
46 GAMBLING DISORDER 89 0.0329
47 ENTERAL NUTRITION 19 0.0328
48 INFUSION SITE CELLULITIS 17 0.0322
49 PATHOLOGICAL GAMBLING 53 0.0319
50 APPLICATION SITE REACTION 222 0.0315
51 APPLICATION SITE HYPERSENSITIVITY 38 0.0313
52 SLEEP TALKING 53 0.0312
53 DYSKINESIA 1185 0.0291
54 THERAPEUTIC PRODUCT EFFECT VARIABLE 113 0.0291
55 STOMA COMPLICATION 27 0.0266
56 POSTURE ABNORMAL 85 0.0261
57 LIBIDO INCREASED 51 0.0251
58 DEVICE ADHESION ISSUE 379 0.0247
59 INFUSION SITE INFLAMMATION 17 0.0241
60 INFUSION SITE NODULE 23 0.0239
61 BINGE EATING 25 0.0232
62 HALLUCINATION, VISUAL 487 0.0230
63 PRODUCT INEFFECTIVE 18 0.0229
64 PLEUROTHOTONUS 20 0.0221
65 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 23 0.0217
66 APPLICATION SITE DERMATITIS 20 0.0214
67 COMPULSIVE SEXUAL BEHAVIOUR 17 0.0210
68 HALLUCINATION 1502 0.0199
69 APPLICATION SITE PRURITUS 452 0.0199
70 DELUSION 290 0.0186
71 DEVICE CONNECTION ISSUE 37 0.0175
72 APPLICATION SITE ERYTHEMA 454 0.0173
73 TENSION 105 0.0172
74 REBOUND ACID HYPERSECRETION 51 0.0168
75 DRUG EFFECT VARIABLE 19 0.0168
76 NEPHROGENIC ANAEMIA 77 0.0166
77 BLADDER CATHETERISATION 16 0.0165
78 REHABILITATION THERAPY 64 0.0165
79 IMPULSIVE BEHAVIOUR 60 0.0160
80 DEVICE ALARM ISSUE 29 0.0160
81 BEZOAR 22 0.0159
82 YAWNING 42 0.0157
83 ILLUSION 25 0.0151
84 APPLICATION SITE RASH 207 0.0150
85 NOCTURIA 178 0.0146
86 DEVICE KINK 52 0.0143
87 DRUG DOSE TITRATION NOT PERFORMED 26 0.0142
88 PERSECUTORY DELUSION 35 0.0140
89 APPLICATION SITE VESICLES 91 0.0140
90 APPLICATION SITE URTICARIA 30 0.0134
91 ACUTE PSYCHOSIS 33 0.0133
92 HYPERPARATHYROIDISM SECONDARY 33 0.0132
93 DEVICE OCCLUSION 183 0.0130
94 PARKINSONISM 125 0.0128
95 BEHAVIOUR DISORDER 68 0.0126
96 LIVING IN RESIDENTIAL INSTITUTION 23 0.0123
97 OBSESSIVE THOUGHTS 22 0.0122
98 HALLUCINATIONS, MIXED 51 0.0121
99 INFREQUENT BOWEL MOVEMENTS 30 0.0120
100 INFUSION SITE BRUISING 26 0.0120
101 DYSTONIA 233 0.0120
102 OBSESSIVE-COMPULSIVE DISORDER 96 0.0120
103 SLEEP DEFICIT 25 0.0118
104 DYSCHEZIA 35 0.0115
105 FINE MOTOR SKILL DYSFUNCTION 33 0.0114
106 INFUSION SITE REACTION 34 0.0114
107 LOGORRHOEA 40 0.0113
108 PRODUCT RESIDUE PRESENT 61 0.0113
109 TERMINAL INSOMNIA 20 0.0113
110 HYPOKINESIA 164 0.0113
111 APPLICATION SITE SWELLING 55 0.0110
112 DAYDREAMING 17 0.0110
113 FLUID INTAKE REDUCED 55 0.0110
114 PRODUCT DISPENSING ISSUE 47 0.0110
115 INITIAL INSOMNIA 108 0.0105
116 DROOLING 72 0.0104
117 NONSPECIFIC REACTION 56 0.0102
118 VOLVULUS 24 0.0101
119 APPLICATION SITE IRRITATION 123 0.0099
120 THERAPEUTIC PRODUCT EFFECT DELAYED 44 0.0096
121 PNEUMOPERITONEUM 17 0.0092
122 INFUSION SITE INFECTION 21 0.0090
123 FAECES HARD 35 0.0090
124 MEDICAL DEVICE PAIN 19 0.0089
125 MIDDLE INSOMNIA 164 0.0088
126 GASTROINTESTINAL MOTILITY DISORDER 47 0.0088
127 IMMOBILE 38 0.0087
128 POOR QUALITY SLEEP 182 0.0084
129 HYPOMANIA 31 0.0084
130 ABNORMAL DREAMS 232 0.0084
131 NEUROLEPTIC MALIGNANT SYNDROME 99 0.0083
132 DECUBITUS ULCER 68 0.0083
133 MOTOR DYSFUNCTION 83 0.0081
134 DEMENTIA 227 0.0081
135 APPLICATION SITE DISCOLOURATION 33 0.0081
136 SKIN ABRASION 38 0.0080
137 SPINAL STENOSIS 33 0.0080
138 GASTROINTESTINAL HYPOMOTILITY 18 0.0080
139 DERMATITIS CONTACT 91 0.0080
140 HIP SURGERY 43 0.0079
141 WEIGHT ABNORMAL 19 0.0079
142 ORTHOSTATIC HYPOTENSION 136 0.0078
143 DECREASED INTEREST 46 0.0078
144 THERAPEUTIC PRODUCT INEFFECTIVE 30 0.0078
145 PNEUMONIA ASPIRATION 193 0.0077
146 SALIVARY HYPERSECRETION 77 0.0077
147 CATHETER SITE ERYTHEMA 16 0.0075
148 WHEELCHAIR USER 33 0.0074
149 INFUSION SITE ERYTHEMA 62 0.0073
150 DELIRIUM 251 0.0072
151 MOVEMENT DISORDER 231 0.0072
152 PRODUCT AVAILABILITY ISSUE 163 0.0072
153 WALKING AID USER 47 0.0071
154 MICTURITION URGENCY 80 0.0070
155 BEDRIDDEN 92 0.0070
156 CHOKING 136 0.0070
157 SPEECH DISORDER 365 0.0070
158 MOBILITY DECREASED 496 0.0069
159 TREMOR 1142 0.0069
160 SOMNAMBULISM 45 0.0068
161 POTENTIATING DRUG INTERACTION 23 0.0068
162 BALANCE DISORDER 589 0.0068
163 FULL BLOOD COUNT ABNORMAL 72 0.0068
164 BOWEL MOVEMENT IRREGULARITY 51 0.0067
165 ABDOMINAL RIGIDITY 18 0.0066
166 THERAPEUTIC RESPONSE SHORTENED 220 0.0066
167 CLAVICLE FRACTURE 25 0.0065
168 TOXIC ENCEPHALOPATHY 33 0.0065
169 HOSPICE CARE 64 0.0065
170 CERVICAL VERTEBRAL FRACTURE 22 0.0064
171 MICTURITION DISORDER 22 0.0063
172 OXYGEN SATURATION ABNORMAL 18 0.0063
173 HIP FRACTURE 202 0.0063
174 PSYCHOTIC DISORDER 185 0.0063
175 INCONTINENCE 66 0.0062
176 COGNITIVE DISORDER 291 0.0062
177 ABNORMAL FAECES 51 0.0062
178 MEDICAL DEVICE DISCOMFORT 19 0.0062
179 FALL 2070 0.0062
180 ASPIRATION 68 0.0062
181 RESTLESSNESS 226 0.0062
182 CATHETER SITE PAIN 16 0.0062
183 PSYCHIATRIC SYMPTOM 45 0.0061
184 METABOLIC ENCEPHALOPATHY 18 0.0060
185 END STAGE RENAL DISEASE 109 0.0060
186 VITAMIN B12 DEFICIENCY 24 0.0059
187 SPINAL OPERATION 73 0.0059
188 PARANOIA 101 0.0059
189 HALLUCINATION, AUDITORY 93 0.0058
190 FEMORAL NECK FRACTURE 30 0.0058
191 CHRONIC KIDNEY DISEASE 444 0.0058
192 INABILITY TO AFFORD MEDICATION 58 0.0058
193 SLEEP APNOEA SYNDROME 111 0.0058
194 ANAL INCONTINENCE 52 0.0058
195 GAIT INABILITY 190 0.0057
196 SEROTONIN SYNDROME 109 0.0057
197 NIGHTMARE 194 0.0056
198 ENERGY INCREASED 33 0.0056
199 INFUSION SITE SWELLING 35 0.0056
200 HYPERSOMNIA 159 0.0055
201 COMA SCALE ABNORMAL 16 0.0055
202 SCREAMING 35 0.0055
203 APPLICATION SITE BURN 27 0.0055
204 AUTONOMIC NERVOUS SYSTEM IMBALANCE 16 0.0055
205 ABNORMAL BEHAVIOUR 216 0.0054
206 IMPAIRED GASTRIC EMPTYING 74 0.0054
207 DYSSTASIA 157 0.0054
208 SUSPECTED SUICIDE 25 0.0053
209 DEVICE PLACEMENT ISSUE 19 0.0053
210 RIB FRACTURE 109 0.0053
211 SNORING 20 0.0053
212 HYPERPHAGIA 21 0.0053
213 INCOHERENT 34 0.0052
214 ANOSMIA 76 0.0052
215 COMMUNICATION DISORDER 20 0.0052
216 GAIT DISTURBANCE 995 0.0052
217 PHARMACEUTICAL PRODUCT COMPLAINT 135 0.0052
218 PSYCHOMOTOR HYPERACTIVITY 86 0.0052
219 DEVICE DISLOCATION 224 0.0051
220 ATRIOVENTRICULAR BLOCK FIRST DEGREE 22 0.0051
221 HYPOPHAGIA 129 0.0050
222 POLYP 33 0.0050
223 HEAD INJURY 159 0.0050
224 CEREBRAL ATROPHY 20 0.0050
225 DYSPHEMIA 22 0.0050
226 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 353 0.0050
227 SOMNOLENCE 996 0.0049
228 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 237 0.0049
229 PANIC DISORDER 19 0.0049
230 INTERVERTEBRAL DISC DEGENERATION 45 0.0049
231 DEPRESSIVE SYMPTOM 17 0.0048
232 DISORIENTATION 191 0.0048
233 MUSCULOSKELETAL STIFFNESS 422 0.0048
234 APHASIA 145 0.0048
235 HUMERUS FRACTURE 23 0.0048
236 INGUINAL HERNIA 29 0.0048
237 UNRESPONSIVE TO STIMULI 123 0.0048
238 FAECALOMA 26 0.0047
239 DYSPHAGIA 450 0.0047
240 SKIN LACERATION 51 0.0047
241 HAND FRACTURE 33 0.0047
242 LIGAMENT SPRAIN 46 0.0046
243 CONFUSIONAL STATE 750 0.0046
244 TERMINAL STATE 31 0.0046
245 FOOT DEFORMITY 51 0.0046
246 DYSARTHRIA 171 0.0045
247 INFARCTION 31 0.0045
248 PRESCRIBED UNDERDOSE 90 0.0045
249 THERAPY INTERRUPTED 321 0.0045
250 FACE INJURY 17 0.0045
251 DEVICE ISSUE 401 0.0045
252 AGGRESSION 221 0.0044
253 SPINAL COMPRESSION FRACTURE 36 0.0043
254 PARALYSIS 62 0.0043
255 FEELING DRUNK 32 0.0043
256 MEMORY IMPAIRMENT 590 0.0043
257 KNEE OPERATION 42 0.0043
258 APATHY 62 0.0042
259 SLEEP DISORDER 299 0.0042
260 THERMAL BURN 30 0.0042
261 ENURESIS 17 0.0042
262 UNEVALUABLE EVENT 317 0.0042
263 URINARY TRACT INFECTION 714 0.0042
264 AGITATION 307 0.0042
265 LUMBAR VERTEBRAL FRACTURE 19 0.0041
266 BRADYPHRENIA 27 0.0041
267 INTENTIONAL UNDERDOSE 30 0.0041
268 DYSGRAPHIA 27 0.0041
269 DEPRESSED MOOD 214 0.0040
270 IMPAIRED QUALITY OF LIFE 58 0.0040
271 DISTURBANCE IN ATTENTION 217 0.0040
272 DIZZINESS POSTURAL 39 0.0040
273 MALABSORPTION 21 0.0040
274 HICCUPS 33 0.0040
275 PRE-EXISTING CONDITION IMPROVED 25 0.0040
276 NEUTROPHIL COUNT INCREASED 41 0.0040
277 BLOOD PRESSURE FLUCTUATION 96 0.0040
278 APPLICATION SITE PAIN 88 0.0040
279 SPINAL OSTEOARTHRITIS 35 0.0040
280 INFUSION SITE PAIN 51 0.0040
281 PRODUCT ADMINISTRATION INTERRUPTED 31 0.0039
282 URINARY INCONTINENCE 117 0.0039
283 DEVICE USE ISSUE 69 0.0039
284 ARTHRITIS INFECTIVE 18 0.0039
285 JOINT DISLOCATION 41 0.0039
286 HAEMORRHAGIC ANAEMIA 17 0.0039
287 SENSORY LOSS 31 0.0038
288 WRIST FRACTURE 46 0.0038
289 EMBEDDED DEVICE 38 0.0038
290 FEEDING DISORDER 77 0.0038
291 DEVICE PHYSICAL PROPERTY ISSUE 29 0.0038
292 INSOMNIA 1001 0.0038
293 MENISCUS INJURY 23 0.0037
294 EATING DISORDER 79 0.0037
295 ILEUS 46 0.0037
296 PRESCRIBED OVERDOSE 71 0.0037
297 RESPIRATORY ARREST 101 0.0037
298 EXERCISE TOLERANCE DECREASED 21 0.0036
299 SLUGGISHNESS 37 0.0036
300 BLOOD IRON DECREASED 43 0.0036
301 LIMB DISCOMFORT 112 0.0036
302 SENSORY DISTURBANCE 58 0.0036
303 UPPER LIMB FRACTURE 72 0.0036
304 STRESS CARDIOMYOPATHY 21 0.0036
305 PELVIC FRACTURE 28 0.0036
306 MENTAL IMPAIRMENT 87 0.0036
307 SEXUAL DYSFUNCTION 42 0.0036
308 DIPLOPIA 92 0.0035
309 BLADDER DISORDER 35 0.0035
310 DECREASED ACTIVITY 38 0.0035
311 MUSCLE TWITCHING 81 0.0035
312 PHOTOPSIA 22 0.0035
313 COVID-19 PNEUMONIA 41 0.0035
314 DIABETIC NEUROPATHY 17 0.0034
315 GENERAL PHYSICAL HEALTH DETERIORATION 396 0.0034
316 TROPONIN INCREASED 26 0.0034
317 MUSCULOSKELETAL DISORDER 65 0.0034
318 INTERNAL HAEMORRHAGE 39 0.0034
319 SKIN REACTION 48 0.0034
320 GASTROOESOPHAGEAL REFLUX DISEASE 273 0.0034
321 SCOLIOSIS 21 0.0034
322 ECONOMIC PROBLEM 51 0.0034
323 MENTAL STATUS CHANGES 93 0.0033
324 POLYNEUROPATHY 40 0.0033
325 PETIT MAL EPILEPSY 17 0.0033
326 LOSS OF CONSCIOUSNESS 426 0.0033
327 PRODUCT PHYSICAL ISSUE 67 0.0033
328 BIPOLAR DISORDER 36 0.0033
329 FORMICATION 23 0.0033
330 LACERATION 31 0.0033
331 TRANSIENT ISCHAEMIC ATTACK 111 0.0033
332 MANIA 54 0.0033
333 HYPERVENTILATION 19 0.0033
334 PRODUCT DISTRIBUTION ISSUE 30 0.0032
335 FOOD CRAVING 17 0.0032
336 COORDINATION ABNORMAL 45 0.0032
337 INSURANCE ISSUE 49 0.0032
338 TORSADE DE POINTES 25 0.0032
339 MUSCLE SPASTICITY 39 0.0032
340 APPETITE DISORDER 21 0.0032
341 OVERWEIGHT 17 0.0032
342 WEIGHT FLUCTUATION 33 0.0032
343 SKIN MASS 21 0.0031
344 CARPAL TUNNEL SYNDROME 44 0.0031
345 SOCIAL AVOIDANT BEHAVIOUR 18 0.0031
346 CEREBRAL DISORDER 23 0.0031
347 CONSTIPATION 678 0.0031
348 EPILEPSY 95 0.0031
349 INTENTIONAL PRODUCT MISUSE 272 0.0031
350 DERMATITIS ALLERGIC 39 0.0031
351 FEMUR FRACTURE 96 0.0031
352 BODY HEIGHT DECREASED 33 0.0031
353 CYSTITIS 98 0.0031
354 TYPE 2 DIABETES MELLITUS 103 0.0031
355 SPUTUM DISCOLOURED 29 0.0031
356 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 27 0.0031
357 AFFECTIVE DISORDER 24 0.0030
358 NERVE COMPRESSION 28 0.0030
359 CATARACT OPERATION 18 0.0030
360 EUPHORIC MOOD 31 0.0030
361 ACUTE RESPIRATORY FAILURE 58 0.0030
362 PERSONALITY CHANGE 28 0.0030
363 BACK DISORDER 49 0.0030
364 MAJOR DEPRESSION 22 0.0030
365 THERAPEUTIC PRODUCT EFFECT DECREASED 134 0.0030
366 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 51 0.0030
367 HYPERHIDROSIS 383 0.0030
368 ANKLE FRACTURE 46 0.0030
369 AGEUSIA 74 0.0030
370 DRY MOUTH 240 0.0030
371 HEAD DISCOMFORT 52 0.0029
372 RENAL FAILURE 388 0.0029
373 POST PROCEDURAL COMPLICATION 56 0.0029
374 PANIC REACTION 21 0.0029
375 THINKING ABNORMAL 54 0.0029
376 RENAL INJURY 86 0.0029
377 ROTATOR CUFF SYNDROME 37 0.0029
378 ALTERED STATE OF CONSCIOUSNESS 62 0.0029
379 PANIC ATTACK 104 0.0029
380 FRACTURE 54 0.0028
381 CARDIO-RESPIRATORY ARREST 119 0.0028
382 THERAPEUTIC RESPONSE UNEXPECTED 127 0.0028
383 SYNCOPE 282 0.0028
384 UROSEPSIS 26 0.0028
385 MUSCULAR WEAKNESS 320 0.0028
386 MUSCLE SPASMS 516 0.0028
387 WITHDRAWAL SYNDROME 118 0.0028
388 KIDNEY INFECTION 55 0.0028
389 HYPERGLYCAEMIA 101 0.0028
390 BLOOD URIC ACID INCREASED 16 0.0028
391 DRUG EFFECT LESS THAN EXPECTED 41 0.0028
392 ATRIAL FLUTTER 22 0.0028
393 KNEE ARTHROPLASTY 58 0.0028
394 HIP ARTHROPLASTY 42 0.0027
395 ANXIETY 780 0.0027
396 INTESTINAL OBSTRUCTION 103 0.0027
397 CONDITION AGGRAVATED 829 0.0027
398 ACUTE KIDNEY INJURY 417 0.0027
399 FRUSTRATION TOLERANCE DECREASED 22 0.0027
400 FEAR 73 0.0027
401 MOOD ALTERED 74 0.0027
402 CONCUSSION 21 0.0027
403 BLOOD PRESSURE DIASTOLIC DECREASED 20 0.0027
404 IRON DEFICIENCY ANAEMIA 25 0.0027
405 ASPHYXIA 22 0.0027
406 FOOT FRACTURE 51 0.0027
407 LOCALISED INFECTION 65 0.0027
408 LIMB INJURY 73 0.0027
409 POST-TRAUMATIC STRESS DISORDER 18 0.0027
410 MALNUTRITION 30 0.0027
411 JOINT INJURY 57 0.0027
412 BLOOD MAGNESIUM DECREASED 23 0.0027
413 AMNESIA 173 0.0027
414 OEDEMA PERIPHERAL 324 0.0027
415 WEIGHT DECREASED 742 0.0027
416 INTERVERTEBRAL DISC PROTRUSION 58 0.0027
417 SECRETION DISCHARGE 33 0.0026
418 PNEUMONIA 853 0.0026
419 TOOTH FRACTURE 29 0.0026
420 AORTIC ANEURYSM 20 0.0026
421 HYPERTHERMIA 20 0.0026
422 COMPLICATION ASSOCIATED WITH DEVICE 38 0.0026
423 GRIP STRENGTH DECREASED 23 0.0026
424 PERIPHERAL SWELLING 402 0.0026
425 DEPRESSION 593 0.0026
426 GLOMERULAR FILTRATION RATE DECREASED 32 0.0026
427 DYSPHONIA 152 0.0026
428 RETCHING 55 0.0026
429 FEELING ABNORMAL 614 0.0026
430 ASTHENIA 960 0.0026
431 IMPAIRED DRIVING ABILITY 29 0.0025
432 OVERDOSE 550 0.0025
433 PERIPHERAL COLDNESS 35 0.0025
434 HAIR DISORDER 21 0.0025
435 DIZZINESS 1271 0.0025
436 HYSTERECTOMY 22 0.0025
437 SEDATION 66 0.0025
438 ACCIDENT 30 0.0025
439 DRUG INTERACTION 398 0.0025
440 LOWER LIMB FRACTURE 48 0.0025
441 BLOOD PRESSURE ABNORMAL 49 0.0025
442 QUALITY OF LIFE DECREASED 33 0.0025
443 INTENTIONAL DOSE OMISSION 70 0.0025
444 DRUG EFFECT INCOMPLETE 89 0.0024
445 BLOOD PRESSURE DECREASED 162 0.0024
446 EXTRASYSTOLES 17 0.0024
447 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 127 0.0024
448 PRODUCT DOSE OMISSION ISSUE 715 0.0024
449 SPINAL DISORDER 23 0.0024
450 URINARY RETENTION 81 0.0024
451 MENTAL DISORDER 105 0.0024
452 DUODENAL ULCER 17 0.0024
453 HAEMORRHOIDS 47 0.0024
454 INCREASED APPETITE 46 0.0024
455 SPINAL FRACTURE 48 0.0024
456 TREATMENT NONCOMPLIANCE 131 0.0024
457 ATRIAL FIBRILLATION 233 0.0024
458 PAROSMIA 18 0.0024
459 NEURALGIA 58 0.0024
460 SCIATICA 38 0.0024
461 SKIN IRRITATION 109 0.0024
462 PRODUCT DOSE OMISSION 155 0.0024
463 ATAXIA 28 0.0024
464 CONTUSION 227 0.0024
465 PRODUCT PRESCRIBING ERROR 56 0.0023
466 ABNORMAL LOSS OF WEIGHT 16 0.0023
467 HYPERTENSIVE CRISIS 26 0.0023
468 LEUKOCYTOSIS 42 0.0023
469 THERAPY CESSATION 119 0.0023
470 HIATUS HERNIA 30 0.0023
471 IRRITABILITY 139 0.0023
472 BLOOD COUNT ABNORMAL 35 0.0023
473 OSTEOPENIA 35 0.0023
474 POLLAKIURIA 96 0.0023
475 LOWER GASTROINTESTINAL HAEMORRHAGE 17 0.0023
476 ARTHROPOD BITE 17 0.0023
477 OSTEOARTHRITIS 97 0.0023
478 GLAUCOMA 44 0.0023
479 HOSPITALISATION 350 0.0023
480 SKIN CANCER 49 0.0023
481 STAPHYLOCOCCAL INFECTION 75 0.0023
482 DEHYDRATION 303 0.0023
483 ROAD TRAFFIC ACCIDENT 95 0.0023
484 TARDIVE DYSKINESIA 64 0.0023
485 DEVICE BREAKAGE 92 0.0023
486 SKIN LESION 62 0.0023
487 NERVOUSNESS 118 0.0023
488 FEELING JITTERY 43 0.0023
489 VITAMIN D DEFICIENCY 22 0.0023
490 HAIR COLOUR CHANGES 28 0.0022
491 HAEMODYNAMIC INSTABILITY 17 0.0022
492 SKIN INFECTION 25 0.0022
493 HERNIA 43 0.0022
494 WOUND 62 0.0022
495 PRODUCT PACKAGING ISSUE 21 0.0022
496 BACK INJURY 24 0.0022
497 HYPOTENSION 442 0.0022
498 FLUID RETENTION 112 0.0022
499 MUSCLE STRAIN 19 0.0022
500 CARDIAC MURMUR 19 0.0022
501 SMALL INTESTINAL OBSTRUCTION 27 0.0022
502 EXOSTOSIS 20 0.0022
503 SKIN SWELLING 19 0.0022
504 TUBULOINTERSTITIAL NEPHRITIS 41 0.0022
505 SURGERY 128 0.0022
506 MYOCLONUS 26 0.0022
507 DEPRESSED LEVEL OF CONSCIOUSNESS 86 0.0022
508 BRAIN FOG 34 0.0022
509 HAEMATOCRIT DECREASED 43 0.0022
510 MALIGNANT MELANOMA 29 0.0022
511 GROIN PAIN 19 0.0022
512 MUSCLE TIGHTNESS 35 0.0022
513 PRODUCT DOSE OMISSION IN ERROR 61 0.0022
514 RESPIRATORY TRACT INFECTION 56 0.0021
515 UPPER GASTROINTESTINAL HAEMORRHAGE 36 0.0021
516 BLOOD POTASSIUM DECREASED 64 0.0021
517 GASTRITIS 56 0.0021
518 GOUT 38 0.0021
519 PULMONARY THROMBOSIS 23 0.0021
520 EMOTIONAL DISORDER 65 0.0021
521 MYASTHENIA GRAVIS 17 0.0021
522 DRUG DISPENSING ERROR 32 0.0021
523 OSTEOPOROSIS 86 0.0021
524 SEIZURE 241 0.0021
525 CATARACT 124 0.0021
526 HEART RATE IRREGULAR 47 0.0021
527 COMPLETED SUICIDE 173 0.0021
528 ERECTILE DYSFUNCTION 53 0.0021
529 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 417 0.0021
530 DEVICE LEAKAGE 89 0.0021
531 SKIN ULCER 53 0.0020
532 SEASONAL ALLERGY 29 0.0020
533 MELAENA 45 0.0020
534 SEPSIS 228 0.0020
535 HEMIPLEGIA 17 0.0020
536 OSTEOMYELITIS 37 0.0020
537 VITREOUS FLOATERS 20 0.0020
538 CARDIOMEGALY 25 0.0020
539 MITRAL VALVE INCOMPETENCE 23 0.0020
540 PRODUCT USE COMPLAINT 32 0.0020
541 OXYGEN SATURATION DECREASED 114 0.0020
542 NASAL CONGESTION 119 0.0020
543 ABASIA 50 0.0020
544 UNDERDOSE 147 0.0020
545 WOUND INFECTION 22 0.0020
546 TOOTH EXTRACTION 25 0.0020
547 GASTROINTESTINAL INFECTION 18 0.0020
548 CELLULITIS 101 0.0020
549 HYPOTONIA 20 0.0020
550 DYSPNOEA EXERTIONAL 75 0.0020
551 ASTHMA 225 0.0020
552 BRONCHITIS 147 0.0020
553 TACHYPNOEA 27 0.0020
554 COLD SWEAT 35 0.0020
555 ADVERSE DRUG REACTION 178 0.0020
556 LYMPHOCYTE COUNT DECREASED 35 0.0020
557 PRODUCT ADMINISTRATION ERROR 40 0.0020
558 BLISTER 111 0.0020
559 SINUS DISORDER 39 0.0020
560 MYOPATHY 17 0.0020
561 DRUG EFFECT DECREASED 106 0.0020
562 BACK PAIN 457 0.0020
563 NEPHROLITHIASIS 90 0.0020
564 CRYING 71 0.0020
565 HYPOAESTHESIA 292 0.0019
566 LOCAL SWELLING 34 0.0019
567 BLOOD URINE PRESENT 37 0.0019
568 PAIN IN EXTREMITY 574 0.0019
569 IMMUNODEFICIENCY 29 0.0019
570 NEUROPATHY PERIPHERAL 185 0.0019
571 FIBROMYALGIA 47 0.0019
572 DECREASED APPETITE 448 0.0019
573 MALAISE 839 0.0019
574 DEATH 1648 0.0019
575 HEART RATE DECREASED 67 0.0019
576 CARDIAC ARREST 157 0.0019
577 BURSITIS 23 0.0019
578 ANGER 64 0.0019
579 SUICIDAL IDEATION 173 0.0019
580 DEVICE RELATED INFECTION 29 0.0019
581 PRODUCT DISPENSING ERROR 41 0.0019
582 CARDIAC FAILURE 151 0.0019
583 HEPATIC STEATOSIS 35 0.0019
584 SPINAL PAIN 22 0.0019
585 DYSURIA 69 0.0019
586 FEELING HOT 114 0.0019
587 BLOOD SODIUM DECREASED 35 0.0019
588 CARDIOVASCULAR DISORDER 47 0.0018
589 SINUS CONGESTION 25 0.0018
590 COVID-19 324 0.0018
591 MYOCARDIAL ISCHAEMIA 21 0.0018
592 NAUSEA 1459 0.0018
593 FATIGUE 1430 0.0018
594 PRODUCT PRESCRIBING ISSUE 40 0.0018
595 THERAPY CHANGE 18 0.0018
596 CARDIAC FAILURE CONGESTIVE 147 0.0018
597 PRODUCT QUALITY ISSUE 248 0.0018
598 CORONARY ARTERY OCCLUSION 25 0.0018
599 ULCER 29 0.0018
600 RHABDOMYOLYSIS 76 0.0018
601 SUBDURAL HAEMATOMA 26 0.0018
602 UNINTENTIONAL MEDICAL DEVICE REMOVAL 21 0.0018
603 TRANSFUSION 19 0.0018
604 ADVERSE REACTION 24 0.0018
605 PRESYNCOPE 44 0.0018
606 DENTAL CARIES 20 0.0018
607 VISUAL IMPAIRMENT 224 0.0018
608 PRODUCTIVE COUGH 86 0.0018
609 WEIGHT INCREASED 403 0.0018
610 ORAL DISCOMFORT 25 0.0018
611 ENCEPHALOPATHY 44 0.0018
612 DRUG INEFFECTIVE 2361 0.0018
613 JOINT RANGE OF MOTION DECREASED 24 0.0018
614 NECK PAIN 100 0.0018
615 MASS 25 0.0018
616 ANHEDONIA 47 0.0018
617 FLUID OVERLOAD 26 0.0018
618 VISION BLURRED 245 0.0018
619 PARAESTHESIA 280 0.0018
620 CANDIDA INFECTION 30 0.0018
621 RESPIRATORY DISTRESS 49 0.0018
622 REBOUND EFFECT 20 0.0018
623 PALLOR 48 0.0018
624 ACUTE MYOCARDIAL INFARCTION 52 0.0018
625 CIRCULATORY COLLAPSE 30 0.0018
626 SINUS BRADYCARDIA 17 0.0018
627 LETHARGY 101 0.0018
628 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 82 0.0018
629 SCAB 20 0.0018
630 COUGH 491 0.0017
631 RED BLOOD CELL COUNT DECREASED 50 0.0017
632 TOOTH INFECTION 23 0.0017
633 BRAIN NEOPLASM 16 0.0017
634 CLOSTRIDIUM DIFFICILE INFECTION 38 0.0017
635 PERITONITIS 36 0.0017
636 PHARYNGEAL SWELLING 17 0.0017
637 BLOOD CREATINE PHOSPHOKINASE INCREASED 50 0.0017
638 GASTRIC ULCER 33 0.0017
639 HYPOXIA 61 0.0017
640 ELECTROLYTE IMBALANCE 20 0.0017
641 HAEMOPTYSIS 48 0.0017
642 HAIR TEXTURE ABNORMAL 23 0.0017
643 OFF LABEL USE 1498 0.0017
644 VOMITING 802 0.0017
645 CEREBRAL HAEMORRHAGE 61 0.0017
646 EXTRA DOSE ADMINISTERED 69 0.0017
647 SWOLLEN TONGUE 53 0.0017
648 GENERALISED TONIC-CLONIC SEIZURE 28 0.0017
649 ARTHRITIS 133 0.0017
650 VERTIGO 103 0.0017
651 AKATHISIA 23 0.0017
652 C-REACTIVE PROTEIN INCREASED 61 0.0017
653 BLOOD PRESSURE INCREASED 256 0.0017
654 HYPERLIPIDAEMIA 20 0.0017
655 MEDICATION ERROR 93 0.0017
656 RESPIRATORY FAILURE 122 0.0017
657 SARS-COV-2 TEST POSITIVE 22 0.0017
658 CEREBROVASCULAR ACCIDENT 282 0.0017
659 TOOTH DISORDER 37 0.0017
660 ILLNESS 171 0.0017
661 HAEMATEMESIS 42 0.0017
662 DISCOMFORT 101 0.0017
663 RECTAL HAEMORRHAGE 71 0.0017
664 EXTRAPYRAMIDAL DISORDER 41 0.0016
665 APHONIA 23 0.0016
666 MYDRIASIS 21 0.0016
667 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 30 0.0016
668 GALLBLADDER DISORDER 29 0.0016
669 THERAPY NON-RESPONDER 73 0.0016
670 PRODUCT USE ISSUE 305 0.0016
671 ABDOMINAL DISTENSION 169 0.0016
672 SCRATCH 17 0.0016
673 BURNING SENSATION 113 0.0016
674 CYST 20 0.0016
675 BLOOD POTASSIUM INCREASED 26 0.0016
676 NEUROTOXICITY 28 0.0016
677 CHROMATURIA 36 0.0016
678 PARAESTHESIA ORAL 23 0.0016
679 DYSPNOEA 902 0.0016
680 DIVERTICULITIS 44 0.0016
681 GASTROINTESTINAL HAEMORRHAGE 132 0.0016
682 MUSCLE ATROPHY 20 0.0016
683 HAEMATURIA 54 0.0016
684 CHOLECYSTECTOMY 18 0.0016
685 PHARYNGITIS STREPTOCOCCAL 17 0.0016
686 MOOD SWINGS 50 0.0016
687 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 86 0.0016
688 ACTIVITIES OF DAILY LIVING IMPAIRED 31 0.0016
689 GASTRIC HAEMORRHAGE 18 0.0016
690 ORAL PAIN 35 0.0016
691 PAIN 960 0.0016
692 HYPERTENSION 330 0.0016
693 BLOOD UREA INCREASED 26 0.0016
694 NIGHT SWEATS 50 0.0016
695 SUICIDE ATTEMPT 94 0.0015
696 HAEMATOMA 40 0.0015
697 ARRHYTHMIA 73 0.0015
698 RESPIRATORY DISORDER 46 0.0015
699 HYPOCALCAEMIA 29 0.0015
700 INCORRECT DOSE ADMINISTERED 349 0.0015
701 MULTIPLE SCLEROSIS 73 0.0015
702 RASH MACULAR 53 0.0015
703 WRONG TECHNIQUE IN DRUG USAGE PROCESS 55 0.0015
704 THIRST 27 0.0015
705 MUSCULOSKELETAL DISCOMFORT 26 0.0015
706 FEELING COLD 42 0.0015
707 MACULAR DEGENERATION 18 0.0015
708 OBESITY 24 0.0015
709 BREAST PAIN 16 0.0015
710 DEVICE DIFFICULT TO USE 99 0.0015
711 DYSPEPSIA 147 0.0015
712 THYROID DISORDER 23 0.0015
713 PULMONARY HYPERTENSION 31 0.0015
714 INCORRECT DOSE ADMINISTERED BY DEVICE 39 0.0015
715 JOINT STIFFNESS 39 0.0015
716 HYPERKALAEMIA 52 0.0015
717 FLATULENCE 84 0.0015
718 INCORRECT PRODUCT ADMINISTRATION DURATION 32 0.0015
719 HEMIPARESIS 25 0.0015
720 TACHYCARDIA 131 0.0015
721 PULMONARY OEDEMA 66 0.0015
722 HYPONATRAEMIA 83 0.0015
723 UPPER RESPIRATORY TRACT INFECTION 68 0.0015
724 INFLUENZA 164 0.0015
725 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 265 0.0015
726 DISABILITY 29 0.0015
727 MADAROSIS 17 0.0015
728 CHOLELITHIASIS 48 0.0015
729 PLEURAL EFFUSION 89 0.0015
730 CYANOSIS 23 0.0015
731 RENAL DISORDER 68 0.0015
732 TENDON RUPTURE 18 0.0015
733 CHEST PAIN 269 0.0015
734 BLOOD ALKALINE PHOSPHATASE INCREASED 36 0.0014
735 CARDIAC DISORDER 135 0.0014
736 ORAL CANDIDIASIS 19 0.0014
737 FUNGAL INFECTION 48 0.0014
738 OEDEMA 78 0.0014
739 SKIN DISCOLOURATION 66 0.0014
740 HOT FLUSH 108 0.0014
741 INFECTION 206 0.0014
742 HEART RATE INCREASED 141 0.0014
743 MULTIPLE SCLEROSIS RELAPSE 97 0.0014
744 LIP SWELLING 47 0.0014
745 SWELLING 132 0.0014
746 SINUS TACHYCARDIA 20 0.0014
747 COMA 67 0.0014
748 ABDOMINAL DISCOMFORT 236 0.0014
749 THROMBOSIS 113 0.0014
750 HAEMOGLOBIN DECREASED 144 0.0014
751 MULTIPLE FRACTURES 23 0.0014
752 HYPOACUSIS 60 0.0014
753 CEREBRAL INFARCTION 34 0.0014
754 DRUG WITHDRAWAL SYNDROME 122 0.0014
755 GASTROENTERITIS VIRAL 25 0.0014
756 PERICARDIAL EFFUSION 32 0.0014
757 WHITE BLOOD CELL COUNT INCREASED 53 0.0014
758 PULMONARY ARTERIAL HYPERTENSION 20 0.0014
759 TASTE DISORDER 28 0.0014
760 NERVOUS SYSTEM DISORDER 43 0.0014
761 RHINORRHOEA 89 0.0014
762 MYOCARDIAL INFARCTION 240 0.0014
763 GENERALISED OEDEMA 17 0.0014
764 ILL-DEFINED DISORDER 83 0.0014
765 HUNGER 19 0.0014
766 ANAEMIA 259 0.0014
767 INTENTIONAL OVERDOSE 87 0.0014
768 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 23 0.0014
769 EXPIRED PRODUCT ADMINISTERED 45 0.0014
770 ERUCTATION 26 0.0013
771 SCAR 23 0.0013
772 CHOLECYSTITIS 16 0.0013
773 COLON CANCER 20 0.0013
774 FULL BLOOD COUNT DECREASED 27 0.0013
775 CHEST DISCOMFORT 136 0.0013
776 SINUSITIS 136 0.0013
777 JOINT SWELLING 160 0.0013
778 DRUG INTOLERANCE 128 0.0013
779 HYPOKALAEMIA 61 0.0013
780 LABORATORY TEST ABNORMAL 39 0.0013
781 SKIN DISORDER 44 0.0013
782 ARTHROPATHY 73 0.0013
783 ABDOMINAL PAIN 305 0.0013
784 RENAL IMPAIRMENT 110 0.0013
785 HERPES ZOSTER 75 0.0013
786 HAEMATOCHEZIA 72 0.0013
787 TOOTH LOSS 27 0.0013
788 BLOOD GLUCOSE ABNORMAL 24 0.0013
789 ERYTHEMA 267 0.0013
790 ARTHRALGIA 539 0.0013
791 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 92 0.0013
792 FAECES DISCOLOURED 28 0.0013
793 PANCREATITIS ACUTE 29 0.0013
794 HEADACHE 805 0.0013
795 MYALGIA 217 0.0013
796 PULMONARY MASS 19 0.0013
797 ABDOMINAL PAIN UPPER 262 0.0013
798 PRURITUS 488 0.0013
799 DIALYSIS 18 0.0013
800 BLOOD LACTATE DEHYDROGENASE INCREASED 20 0.0013
801 PROCEDURAL PAIN 35 0.0013
802 HYPOAESTHESIA ORAL 19 0.0013
803 DIARRHOEA 804 0.0012
804 INJURY 87 0.0012
805 ADVERSE EVENT 114 0.0012
806 PROSTATIC SPECIFIC ANTIGEN INCREASED 17 0.0012
807 DIABETES MELLITUS 94 0.0012
808 ISCHAEMIC STROKE 22 0.0012
809 LYMPHOMA 19 0.0012
810 MUSCULOSKELETAL CHEST PAIN 19 0.0012
811 BRADYCARDIA 65 0.0012
812 PHOTOPHOBIA 23 0.0012
813 EYE DISORDER 40 0.0012
814 MIGRAINE 116 0.0012
815 CHILLS 142 0.0012
816 DRUG ADMINISTRATION ERROR 37 0.0012
817 BLINDNESS UNILATERAL 17 0.0012
818 DERMATITIS 25 0.0012
819 LACRIMATION INCREASED 36 0.0012
820 INTENTIONAL PRODUCT USE ISSUE 104 0.0012
821 ANGINA PECTORIS 34 0.0012
822 EAR PAIN 23 0.0012
823 THROAT IRRITATION 53 0.0012
824 SHOCK 27 0.0012
825 THERAPEUTIC RESPONSE DECREASED 71 0.0012
826 PRODUCT SUBSTITUTION ISSUE 67 0.0012
827 INFLAMMATION 60 0.0012
828 TENDONITIS 18 0.0012
829 DRUG DOSE OMISSION 192 0.0012
830 RASH GENERALISED 30 0.0012
831 PRURITUS GENERALISED 25 0.0012
832 BASAL CELL CARCINOMA 18 0.0012
833 PALPITATIONS 135 0.0012
834 GASTROINTESTINAL DISORDER 103 0.0011
835 BLOOD CREATININE INCREASED 75 0.0011
836 HYPERSENSITIVITY 213 0.0011
837 SKIN HAEMORRHAGE 17 0.0011
838 COAGULOPATHY 19 0.0011
839 PNEUMOTHORAX 18 0.0011
840 ABSCESS 18 0.0011
841 MUSCULOSKELETAL PAIN 59 0.0011
842 PULMONARY EMBOLISM 107 0.0011
843 WHEEZING 66 0.0011
844 PHARYNGEAL OEDEMA 17 0.0011
845 BLINDNESS 45 0.0011
846 DEVICE DEFECTIVE 19 0.0011
847 CORONARY ARTERY DISEASE 33 0.0011
848 PYREXIA 377 0.0011
849 DRY EYE 54 0.0011
850 METASTASES TO LIVER 19 0.0011
851 BONE PAIN 63 0.0011
852 FLUSHING 109 0.0011
853 RESPIRATORY TRACT CONGESTION 17 0.0011
854 RASH 466 0.0011
855 IMPAIRED HEALING 35 0.0011
856 EPISTAXIS 79 0.0011
857 LOWER RESPIRATORY TRACT INFECTION 48 0.0011
858 NASOPHARYNGITIS 194 0.0011
859 VIRAL INFECTION 35 0.0011
860 HYPOGLYCAEMIA 51 0.0011
861 TOOTHACHE 19 0.0010
862 BONE DISORDER 19 0.0010
863 LUNG DISORDER 51 0.0010
864 RENAL FAILURE ACUTE 44 0.0010
865 FREQUENT BOWEL MOVEMENTS 28 0.0010
866 THROAT TIGHTNESS 28 0.0010
867 NEOPLASM MALIGNANT 69 0.0010
868 RASH PRURITIC 56 0.0010
869 BODY TEMPERATURE INCREASED 21 0.0010
870 OROPHARYNGEAL PAIN 95 0.0010
871 CONTRAINDICATED PRODUCT ADMINISTERED 31 0.0010
872 PLATELET COUNT DECREASED 109 0.0010
873 BACTERIAL INFECTION 19 0.0010
874 DEVICE MALFUNCTION 71 0.0010
875 METABOLIC ACIDOSIS 32 0.0010
876 DEEP VEIN THROMBOSIS 65 0.0010
877 GLYCOSYLATED HAEMOGLOBIN INCREASED 25 0.0010
878 STEVENS-JOHNSON SYNDROME 22 0.0010
879 DRUG PRESCRIBING ERROR 19 0.0010
880 MULTIPLE ORGAN DYSFUNCTION SYNDROME 28 0.0010
881 PRODUCT USE IN UNAPPROVED INDICATION 244 0.0010
882 TINNITUS 45 0.0010
883 DEVICE USE ERROR 34 0.0010
884 EAR INFECTION 26 0.0010
885 ORAL HERPES 19 0.0010
886 DYSGEUSIA 72 0.0010
887 ALOPECIA 189 0.0010
888 HEPATIC CIRRHOSIS 18 0.0010
889 EYE PAIN 54 0.0010
890 PAIN IN JAW 27 0.0010
891 INTERNATIONAL NORMALISED RATIO INCREASED 27 0.0009
892 WHITE BLOOD CELL COUNT DECREASED 102 0.0009
893 STOMATITIS 57 0.0009
894 IRRITABLE BOWEL SYNDROME 20 0.0009
895 GASTRIC DISORDER 32 0.0009
896 JAUNDICE 25 0.0009
897 HAEMORRHAGE 97 0.0009
898 BLOOD PRESSURE SYSTOLIC INCREASED 18 0.0009
899 DEAFNESS 24 0.0009
900 BLOOD GLUCOSE DECREASED 44 0.0009
901 DEVICE DELIVERY SYSTEM ISSUE 25 0.0009
902 ABDOMINAL PAIN LOWER 23 0.0009
903 EMOTIONAL DISTRESS 110 0.0009
904 HYPOTHYROIDISM 29 0.0009
905 DISEASE RECURRENCE 43 0.0009
906 PROTEINURIA 17 0.0009
907 SNEEZING 20 0.0009
908 SWELLING FACE 57 0.0009
909 COLITIS 33 0.0009
910 SKIN FISSURES 17 0.0009
911 PSORIATIC ARTHROPATHY 35 0.0009
912 TRANSAMINASES INCREASED 19 0.0009
913 SKIN EXFOLIATION 72 0.0009
914 DRUG ABUSE 71 0.0009
915 INFLUENZA LIKE ILLNESS 70 0.0008
916 RASH PAPULAR 19 0.0008
917 DISEASE PROGRESSION 100 0.0008
918 IMPAIRED WORK ABILITY 18 0.0008
919 INTENTIONAL SELF-INJURY 17 0.0008
920 PANCYTOPENIA 47 0.0008
921 INJECTION SITE MASS 31 0.0008
922 ACCIDENTAL OVERDOSE 30 0.0008
923 PANCREATITIS 43 0.0008
924 VISUAL ACUITY REDUCED 27 0.0008
925 LUNG NEOPLASM MALIGNANT 33 0.0008
926 EYE IRRITATION 46 0.0008
927 LIVER FUNCTION TEST INCREASED 17 0.0008
928 BLOOD GLUCOSE INCREASED 149 0.0008
929 INFUSION RELATED REACTION 52 0.0008
930 URTICARIA 131 0.0008
931 OCULAR HYPERAEMIA 37 0.0008
932 HEPATIC FUNCTION ABNORMAL 29 0.0008
933 RASH ERYTHEMATOUS 37 0.0008
934 BLOOD CHOLESTEROL INCREASED 36 0.0008
935 GLOSSODYNIA 17 0.0008
936 SEPTIC SHOCK 33 0.0008
937 INJECTION SITE BRUISING 60 0.0008
938 ELECTROCARDIOGRAM QT PROLONGED 27 0.0007
939 ASPARTATE AMINOTRANSFERASE INCREASED 38 0.0007
940 PSORIASIS 93 0.0007
941 PRODUCT COMPLAINT 18 0.0007
942 THROMBOCYTOPENIA 79 0.0007
943 CONVULSION 40 0.0007
944 RHEUMATOID ARTHRITIS 79 0.0007
945 PANCREATIC CARCINOMA 20 0.0007
946 ANGIOEDEMA 30 0.0007
947 LIVER DISORDER 30 0.0007
948 INCORRECT DRUG ADMINISTRATION DURATION 19 0.0007
949 EYE SWELLING 25 0.0007
950 BONE DENSITY DECREASED 21 0.0007
951 DRUG-INDUCED LIVER INJURY 21 0.0007
952 PNEUMONITIS 18 0.0007
953 LYMPHADENOPATHY 23 0.0006
954 TOXICITY TO VARIOUS AGENTS 109 0.0006
955 INJECTION SITE ERYTHEMA 80 0.0006
956 LEUKOPENIA 32 0.0006
957 ANAPHYLACTIC SHOCK 16 0.0006
958 LIVER FUNCTION TEST ABNORMAL 18 0.0006
959 ECZEMA 32 0.0006
960 INJECTION SITE REACTION 42 0.0006
961 ALANINE AMINOTRANSFERASE INCREASED 37 0.0006
962 NEEDLE ISSUE 17 0.0006
963 ASCITES 17 0.0006
964 HEPATIC ENZYME INCREASED 39 0.0006
965 INJECTION SITE PRURITUS 38 0.0006
966 INJECTION SITE HAEMORRHAGE 45 0.0006
967 DRY SKIN 75 0.0006
968 BLADDER CANCER 33 0.0006
969 OSTEONECROSIS 18 0.0005
970 NO ADVERSE EVENT 98 0.0005
971 EYE PRURITUS 18 0.0005
972 SYSTEMIC LUPUS ERYTHEMATOSUS 19 0.0005
973 SKIN BURNING SENSATION 38 0.0005
974 NEUTROPENIA 71 0.0005
975 PRODUCT STORAGE ERROR 45 0.0005
976 INJECTION SITE PAIN 157 0.0005
977 DEPENDENCE 28 0.0005
978 ANAPHYLACTIC REACTION 28 0.0005
979 INJECTION SITE SWELLING 38 0.0005
980 DERMATITIS ATOPIC 26 0.0005
981 PLASMA CELL MYELOMA 19 0.0005
982 PROSTATE CANCER 36 0.0004
983 ACCIDENTAL EXPOSURE TO PRODUCT 36 0.0003
984 BREAST CANCER 32 0.0003
985 FEBRILE NEUTROPENIA 22 0.0003
986 DRUG DEPENDENCE 52 0.0003
987 TREATMENT FAILURE 26 0.0003
988 ACNE 23 0.0003
989 DEVICE EXPULSION 18 0.0003
990 DRUG DOSE OMISSION BY DEVICE 21 0.0003
991 MALIGNANT NEOPLASM PROGRESSION 27 0.0003